COVID-19 Antibody Testing Moves Center-Stage In Germany With Major Input From Roche
Roche Diagnostics is promising a €400m investment at the site in Bavaria that has developed its new COVID-19 antibody test kits, three million of which will be delivered to German health care professionals in May.
You may also be interested in...
Fact File: European COVID-19 Focus Shifts To Managing The ‘New Normal’
The evolution of how and where patients receive their care has received an unexpected boost from the COVID-19 crisis. Coronavirus volume testing challenges persist, but the global medtech industry is now looking beyond the crisis toward a return to “normal” business.
FDA Grants EUA For Roche’s Coronavirus Antibody Test
The company says the serology test has a specificity of 99.8% and sensitivity of 100%
Developing Antibody Tests Is Technically The Biggest COVID-19 Challenge Yet
The COVID-19 antibody tests that so far have gone through the validation process have not proven accurate enough to be rolled out for public use, says the UK. A new rapid test consortium is working on a solution.